A cell-free genomics approach silences cellular noise and reveals transcription drivers, improving our understanding of a ...

BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by ...

BV100 Phase 1, single- and multiple-ascending dose clinical trial data include pharmacokinetics, safety and tolerability data. BV100 demonstrated a dose-proportional pharmacokinetic profile and was ...

To support drug discovery, a new study has revealed fundamental features of the transcription cycle in the bacteria that causes tuberculosis.

The Forum on Microbial Threats hosts public workshops and supports various other events and publications produced by global ...

Significantly more patients treated with once-daily, oral Sotyktu achieved an ACR20 response compared with placebo at Week 16 in the pivotal Phase 3 POETYK PsA-1 and POETYK PsA-2 clinical ...

A case of tuberculosis has been confirmed at two Long Island schools, Bethpage High School and Patchogue-Medford High School, according to a letter sent home to parents and guardians. In Bethpage, the ...

In today’s interconnected world, the spread of pathogenic microorganisms poses a significant challenge to global public health, economic stability, and ...

Background Psoriatic disease has a complex effect on bone metabolism, resulting in both pathological bone formation and bone resorption. However, microstructural changes in cortical and trabecular ...

A conserved glucagon signaling pathway links high-fat diet-induced metabolic imbalance to cardiac arrhythmia through hormone-producing cells and heart-innervating neurons that regulate rhythmicity.